(Rac)-Rotigotine Hydrochloride: FAQs for Researchers

(Rac)-Rotigotine hydrochloride is the racemic hydrochloride salt form of Rotigotine, a non-ergoline dopamine agonist used as a pharmacological research tool to study dopaminergic receptor signaling, Parkinson's disease models, and related CNS pathways.

Chemical Name

(Rac)-Rotigotine hydrochloride (racemic mixture of R- and S-enantiomers)

Pharmacological Class

Non-ergoline dopamine receptor agonist (D1–D5 activity reported for the active enantiomer)

SKU / Catalog Number

R302088

Salt Form

Hydrochloride salt, improving aqueous solubility relative to free base

Research Application

In vitro receptor binding assays, cell-based dopaminergic signaling studies, CNS disease modeling

Chirality

Racemic; the S(-)-enantiomer is the pharmacologically active form used clinically

What Is (Rac)-Rotigotine Hydrochloride?

(Rac)-Rotigotine hydrochloride is the racemic hydrochloride salt of Rotigotine, a non-ergoline dopamine agonist. The racemic mixture contains equal proportions of the S(-) and R(+) enantiomers. The S(-) form is the pharmacologically active enantiomer responsible for dopamine receptor agonism, while the R(+) form serves as an internal stereochemical reference and control in research settings. As a hydrochloride salt, this compound offers improved stability and aqueous solubility compared with the free base, making it practical for preparation of stock solutions in laboratory workflows.

In the context of CNS pharmacology research, Rotigotine acts on multiple dopamine receptor subtypes (D1 through D5) as well as certain serotonin and adrenergic receptors, providing a broad pharmacological profile that researchers exploit to dissect dopaminergic pathway contributions in disease models.

Solubility, Reconstitution, and Stock Solution Preparation

As a hydrochloride salt, (Rac)-Rotigotine hydrochloride is expected to exhibit moderate to good solubility in water and polar protic solvents such as DMSO and ethanol. Researchers commonly prepare a concentrated stock solution in DMSO (e.g., 10–50 mM) and subsequently dilute into aqueous assay buffer to the desired working concentration. It is important to ensure that the final DMSO concentration in cell-based assays does not exceed 0.1–0.5% (v/v) to avoid cytotoxic artefacts.

For aqueous preparation, dissolve in sterile phosphate-buffered saline (PBS) or water with gentle warming if necessary. Prepare fresh solutions where possible, or aliquot stock solutions and store at –20 °C under inert atmosphere to minimize oxidative degradation. Always verify final concentration by UV absorbance or HPLC when precision is critical.

Note: Specific solubility values for this lot should be confirmed in the certificate of analysis (CoA) supplied with the product or by contacting Aladdin Scientific technical support.

Storage, Stability, and Handling Precautions

Store (Rac)-Rotigotine hydrochloride as a dry solid at –20 °C, protected from light and moisture. The compound contains a thienyl group susceptible to oxidation; therefore, storage under argon or nitrogen and use of amber vials is recommended. Once reconstituted, aliquots should be stored at –20 °C and repeated freeze-thaw cycles should be minimized.

From a safety standpoint, handle this compound in accordance with standard laboratory practices for potent pharmacological agents. Use appropriate personal protective equipment (PPE) including gloves, lab coat, and eye protection. Consult the Safety Data Sheet (SDS) prior to use for information on hazard classification, first-aid measures, and disposal requirements. As a dopamine agonist, inadvertent exposure may elicit pharmacological effects; avoid inhalation of dust or aerosols.

Research Applications and Experimental Considerations

(Rac)-Rotigotine hydrochloride is used in research settings as a tool compound for dopaminergic pharmacology. Key applications include:

• Receptor binding assays: Competitive radioligand binding to D2/D3 receptors to determine Ki values and selectivity profiles, using the racemic compound as a reference standard or in enantiomeric comparisons.
• Cell-based functional assays: cAMP accumulation, β-arrestin recruitment, and calcium flux assays in cell lines expressing recombinant dopamine receptors.
• In vitro neurotoxicity and neuroprotection studies: Assessment of dopaminergic neuron survival in primary cultures or neuroblastoma cell lines.
• Parkinson's disease models: Complementary use alongside selective enantiomers in rodent or cell-based 6-OHDA or MPTP models to distinguish pharmacological from non-pharmacological contributions.

When designing experiments, researchers should account for the presence of both enantiomers and consider running parallel assays with the pure S(-)-enantiomer (Rotigotine) to delineate enantiospecific effects. Appropriate vehicle controls (matched solvent) must be included in all assays.

Ordering, Purity, and Quality Assurance

(Rac)-Rotigotine hydrochloride is available from Aladdin Scientific under catalog number R302088. Each lot is accompanied by a Certificate of Analysis (CoA) confirming identity, purity, and appearance. Purity is typically assessed by HPLC; researchers requiring specific purity thresholds should consult the CoA or contact Aladdin Scientific for lot-specific data prior to ordering.

For bulk quantities, custom synthesis, or additional characterization data (NMR, MS, elemental analysis), please contact Aladdin Scientific's technical sales team. Orders can be placed through the Aladdin Scientific website or via your institutional procurement system. Returns and replacements are handled in accordance with Aladdin Scientific's standard return policy; please retain the original packaging and CoA for any quality-related inquiries.

Frequently asked questions

What is the difference between (Rac)-Rotigotine hydrochloride and Rotigotine?

(Rac)-Rotigotine hydrochloride is the racemic hydrochloride salt containing equal parts of the S(-) and R(+) enantiomers, while the clinical drug Rotigotine refers specifically to the pharmacologically active S(-)-enantiomer. The racemic form is used in research as a reference compound, for stereochemical comparisons, or in assays where the contribution of each enantiomer is under investigation.

In which solvents can (Rac)-Rotigotine hydrochloride be dissolved for laboratory use?

As a hydrochloride salt, (Rac)-Rotigotine hydrochloride is expected to be soluble in DMSO, ethanol, and water. DMSO stock solutions (10–50 mM) are commonly used, followed by dilution into aqueous buffer for assays. Specific solubility data should be confirmed in the product CoA or by contacting Aladdin Scientific technical support, as values can vary by lot.

How should (Rac)-Rotigotine hydrochloride be stored to maintain stability?

Store the dry compound at –20 °C, protected from light and moisture, preferably under an inert atmosphere (argon or nitrogen) in amber vials. Reconstituted solutions should be aliquoted, stored at –20 °C, and freeze-thaw cycles should be minimized. Always check the CoA for lot-specific storage recommendations.

What dopamine receptor subtypes does Rotigotine act on?

The active S(-)-enantiomer of Rotigotine has reported agonist activity at D1, D2, D3, D4, and D5 dopamine receptors, with preference for D2-family receptors (D2, D3). It also shows activity at certain serotonergic and adrenergic receptor subtypes. Researchers using the racemic form should note that both enantiomers may contribute to observed receptor interactions, and comparative studies with the pure enantiomers are recommended to delineate enantiospecific effects.

Can (Rac)-Rotigotine hydrochloride be used in animal studies?

The racemic compound may be used in preclinical animal studies, particularly where the researcher wishes to compare enantiomers or use the racemate as a reference control. For in vivo use, formulation, dose, route of administration, and ethical approvals must be determined by the investigator according to institutional guidelines. Aladdin Scientific supplies this compound for research purposes only and does not provide veterinary or clinical dosing advice.

References

1. Watts RL et al. Rotigotine: pharmacological profile of a dopamine agonist. Expert Review of Neurotherapeutics. Review of dopamine receptor pharmacology of Rotigotine.
2. Muller T. Rotigotine patch (Neupro) for the treatment of Parkinson's disease. Expert Review of Neurotherapeutics. General pharmacological background reference.
3. Scheller D et al. Receptor binding profile and pharmacological characterization of Rotigotine. General dopamine receptor selectivity reference.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.